Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Hemasphere|January 26, 2023
Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell TherapyConrad-Amadeus Voltin, Philipp Gödel, Laura Beckmann, et al.Haematologica|March 5, 2026
Impact of FMS-like tyrosine kinase 3 inhibitor maintenance on post-transplant outcomes in acute myeloid leukemia with FMS-like tyrosine kinase 3 mutations: a real-world German registry analysis highlighting sorafenibRadwan Massoud, Sarah Flossdorf, Franziska Hanke, et al.Bone Marrow Transplantation|April 8, 2026
Haploidentical transplantation with post-transplant cyclophosphamide is not inferior to 9/10-MUD transplantation with ATG in patients with myeloid malignanciesAndrea Gantner, Svenja Labuhn, Daniel Fürst, et al.Haematologica|August 30, 2023
Allogeneic hematopoietic stem cell transplantation in patients aged 60-79 years in Germany (1998-2018): a registry studyJan Frederic Weller, Claudia Lengerke, Jürgen Finke, et al.Bone Marrow Transplantation|December 5, 2024
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myelomaNora Grieb, Alexander Oeser, Maximilian Ferle, et al.Blood|June 12, 2025
Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRSTMaximilian Merz, Nico Gagelmann, Samih Smaili, et al.Journal of Hematology & Oncology|May 21, 2026
Standard-of-care ciltacabtagene autoleucel in earlier versus later lines of therapy for relapsed or refractory multiple myeloma: a nationwide registry analysisNico Gagelmann, Hermann Einsele, Sarah Flossdorf, et al.European Journal of Nuclear Medicine and Molecular Imaging|December 19, 2023
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapyConrad-Amadeus Voltin, Andrea Paccagnella, Michael Winkelmann, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 19, 2026
Risk Assessment in Large B-Cell Lymphoma Using Metabolic Tumor Volume: Real-World Data from a Multicenter Cohort of Patients Undergoing CAR T-Cell TherapyConrad-Amadeus Voltin, Sarah Flossdorf, Lars Kurch, et al.Pageof 2